Ibuprofen + Paracetamol Tablet Franchise in Ahmedabad

Pain & Fever Relief Tablet Supplier in Bangalore

Dual-Action Analgesic Tablet Distributor in Hyderabad

Anti-Inflammatory & Analgesic Tablet Franchise Opportunity in Jaipur

Headache & Musculoskeletal Pain Tablet Stockist in Mumbai
Ibuprofen + Paracetamol Tablet Manufacturing & Export in Chandigarh

Home/Products /ibuprofen-400mg-paracetamol-500mg-tablet

Ibutyle P 500 Tablet

Composition : Ibuprofen (400mg) + Paracetamol (500mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Ibutyle P 500 Tablet combines Ibuprofen 400mg and Paracetamol 500mg to deliver potent dual-action relief from pain and fever. This combination is ideal for headaches, dental pain, musculoskeletal discomfort, arthritis flare-ups, postoperative pain, and mild fever.

Ibuprofen reduces inflammation and swelling as a non-steroidal anti-inflammatory drug (NSAID), while Paracetamol offers antipyretic and analgesic effects. Together, they provide faster and more comprehensive symptomatic relief than either medicine alone.

The tablet is widely prescribed across general medicine, orthopedics, dentistry, gynecology, and hospital outpatient care. Its broad application ensures steady demand in pharmacies, hospitals, clinics, and institutional healthcare facilities.

Adding Ibutyle P 500 Tablet strengthens the pain management and anti-inflammatory therapy segment, offering strong opportunities in retail pharmacy distribution, hospital supply chains, institutional bulk orders, export markets, and third-party manufacturing. Its high prescription frequency makes it a valuable and profitable product for pharmaceutical distributors.

Read More

About the Product

Ibutyle P 500 Tablet combines Ibuprofen 400mg and Paracetamol 500mg to deliver potent dual-action relief from pain and fever. This combination is ideal for headaches, dental pain, musculoskeletal discomfort, arthritis flare-ups, postoperative pain, and mild fever.

Ibuprofen reduces inflammation and swelling as a non-steroidal anti-inflammatory drug (NSAID), while Paracetamol offers antipyretic and analgesic effects. Together, they provide faster and more comprehensive symptomatic relief than either medicine alone.

The tablet is widely prescribed across general medicine, orthopedics, dentistry, gynecology, and hospital outpatient care. Its broad application ensures steady demand in pharmacies, hospitals, clinics, and institutional healthcare facilities.

Adding Ibutyle P 500 Tablet strengthens the pain management and anti-inflammatory therapy segment, offering strong opportunities in retail pharmacy distribution, hospital supply chains, institutional bulk orders, export markets, and third-party manufacturing. Its high prescription frequency makes it a valuable and profitable product for pharmaceutical distributors.

Some patients may experience nausea, heartburn, dizziness, gastric irritation, headache, or mild gastrointestinal discomfort. Rarely, prolonged use may cause gastrointestinal bleeding, kidney impairment, or allergic reactions.

Ibutyle P 500 Tablet is indicated for the treatment of moderate to severe pain including musculoskeletal pain, arthritis, backache, dental pain, headaches, fever, and dysmenorrhea, as advised by a healthcare professional.

Use strictly under medical supervision. Avoid exceeding the prescribed dose and long-term use without guidance. Caution is advised in patients with liver, kidney, stomach, or cardiovascular conditions.

Store Ibutyle P 500 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation